Publications by authors named "Tinghai Yi"
Article Synopsis
- Clear cell renal cell carcinoma (ccRCC) has a high incidence and mortality rate, and current treatments yield poor prognostic outcomes for patients.
- *Recent research highlights the potential of methylation modifications as molecular targets in ccRCC, identifying 57 methylation-related genes (MRGs) using data from large cancer databases.
- *A Methylation-Related Risk Score (MARS) was developed, which showed significant prognostic value and the ability to predict immune responses and treatment outcomes in ccRCC patients, aiding in more personalized treatment strategies.
